STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about MCB
Insiders, 180 days
-$2.9M net sold
1 buyer · 4 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.1M
2 notices
Metropolitan Bank insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Metropolitan Bank Holding Corp. insiders sold a net $2.9M of stock across 260 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 10, 2026.
+27.6% median (+24.1% mean) 90-day return after 3 previous buys.
The trade is 3.0% of the 33,197 shares held after it.
No other insider bought within 30 days.
Insider activity: EVP & Chief Financial Officer Dougherty Daniel F bought about $90.0K of MCB on Jul 23, 2026, the largest insider purchase at the company since 2023.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MCB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Fredston Dale C
Filed 2026-09-17
$178.6K
ROBERT C PATENT
Filed 2026-08-10
$928.6K
Nick Rosenberg
Filed 2026-06-26
$439.0K
Executive pay vs shareholder return · Mark DeFazio
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$3.0M
$2.8M
$871.0K
+15%
+16%
2022
$4.6M
$2.0M
$960.7K
+22%
+16%
2021
$4.4M
$8.4M
$1.9M
+121%
+25%
2020
$2.0M
$1.0M
$901.2K
-25%
-9%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.9M sold by insiders over 180 days, $1.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$10.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MCB
FY Dec 2025
$11.1M
FY Dec 2024
$23.9M
FY Dec 2023
$27.9M
FY Dec 2022
$26.9M
FY Dec 2021
$23.2M
Jun 2026
$2.6M
Mar 2026
$2.6M
Dec 2025
$2.4M
Sep 2025
$2.5M
Jun 2025
$2.6M
Mar 2025
$3.6M
Dec 2024
$4.5M
Sep 2024
$6.2M
At each fiscal year end
Single quarter
Net margin, TTM
+860.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MCB
FY Dec 2025
+643.2%
FY Dec 2024
+278.6%
FY Dec 2023
+277.1%
FY Dec 2022
+221.3%
FY Dec 2021
+261.6%
Jun 2026
+743.3%
Mar 2026
+1,205%
Dec 2025
+1,206%
Sep 2025
+286.5%
Jun 2025
+719.0%
Mar 2025
+458.7%
Dec 2024
+471.3%
Sep 2024
+197.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$104.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MCB
FY Dec 2025
$86.7M
FY Dec 2024
$146.5M
FY Dec 2023
$40.5M
FY Dec 2022
$83.9M
FY Dec 2021
$35.3M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity MCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt MCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MCB
FY Dec 2025
+9.7%
FY Dec 2024
+9.6%
FY Dec 2023
+12.5%
FY Dec 2022
+10.5%
FY Dec 2021
+13.5%
Jun 2026
+10.2%
Mar 2026
+10.2%
Dec 2025
+9.7%
Sep 2025
+8.8%
Jun 2025
+9.7%
Mar 2025
+9.5%
Dec 2024
+9.6%
Sep 2024
+8.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCB
FY Dec 2025
+0.9%
FY Dec 2024
+0.9%
FY Dec 2023
+1.2%
FY Dec 2022
+0.9%
FY Dec 2021
+1.1%
Jun 2026
+1.0%
Mar 2026
+1.0%
Dec 2025
+0.9%
Sep 2025
+0.8%
Jun 2025
+0.9%
Mar 2025
+0.9%
Dec 2024
+0.9%
Sep 2024
+0.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital MCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed MCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.39x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MCB
FY Dec 2025
11.55x
FY Dec 2024
9.85x
FY Dec 2023
8.04x
FY Dec 2022
11.11x
FY Dec 2021
16.54x
Jun 2026
12.56x
Mar 2026
10.31x
Dec 2025
11.55x
Sep 2025
12.97x
Jun 2025
11.33x
Mar 2025
9.46x
Dec 2024
9.85x
Sep 2024
9.85x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value MCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield MCB
FY Dec 2025
+11.0%
FY Dec 2024
+22.4%
FY Dec 2023
+6.6%
FY Dec 2022
+13.1%
FY Dec 2021
+3.1%
Jun 2026
+8.6%
Mar 2026
+15.9%
Dec 2025
+11.0%
Sep 2025
+17.9%
Jun 2025
+15.1%
Mar 2025
+20.6%
Dec 2024
+22.4%
Sep 2024
+5.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.46x
P/E over trailing EPS growth of 27%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MCB
FY Dec 2025
1.01x
FY Dec 2024
n/a
FY Dec 2023
0.26x
FY Dec 2022
n/a
FY Dec 2021
0.43x
Jun 2026
0.46x
Mar 2026
0.28x
Dec 2025
1.01x
Sep 2025
1.61x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
1.04x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MCB ranks highest on profitability (46th percentile) and insider conviction (31st), and lowest on growth (1st), among Banks peers.
Profitability
46
Inputs
Return on equity+10.2% · 48 pct, sector of 327
Return on assets+1.0% · 43 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
1
Inputs
Revenue growth, YoY-53.8% · 1 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
31
Inputs
Net Form 4 buying (codes P and S), 180d-$2.9M · 15 pct, sector of 273
Insider buyers, 180d1 · 47 pct, sector of 273
Risk and compliance
23
Inputs
Short interest, % of float+6.2% · 19 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+18.0% · 28 pct, sector of 127
3 not measured: Financial health, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MCB filings, in plain words
Are Metropolitan Bank insiders buying or selling MCB?
In the 180 days to 2026-10-28, Metropolitan Bank insiders were net sellers, a net $2.9M: $90.0K of purchases and $3.0M of sales reported on Form 4, by 1 buyer and 4 sellers.
Are there planned insider sales of MCB?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.1M of stock; the latest, by Fredston Dale C, was filed 2026-09-17.
Read the full summary
In the 180 days to 2026-10-28, Metropolitan Bank insiders were net sellers of MCB, a net $2.9M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. None of the 9 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.